NATERA, INC. (NTRA) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 553.20M USD | Liabilities, Current |
| Cash and equivalents | (m) | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | Marketable Securities, Current · Debt Securities, Available-for-sale, Current · Available-for-sale Securities, Current |
| Customer receivables | 421.97M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 80.35M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $553.20M | (m) | (m) | $421.97M | $80.35M | (m) |
| 2026-03-31 | (m) | $558.26M | (m) | (m) | $417.60M | $70.72M | (m) |
| 2025-12-31 | (m) | $441.23M | (m) | (m) | $296.53M | $68.44M | (m) |
| 2025-09-30 | (m) | $442.02M | (m) | $1.00M | $286.38M | $64.64M | (m) |
| 2025-06-30 | (m) | $384.84M | (m) | $15.97M | $309.22M | $54.27M | (m) |
| 2025-03-31 | (m) | $365.68M | (m) | $17.83M | $318.23M | $50.37M | (m) |
| 2024-12-31 | (m) | $344.05M | (m) | $22.69M | $314.17M | $44.74M | (m) |
| 2024-09-30 | (m) | $301.42M | (m) | $29.49M | $306.88M | $48.72M | (m) |
| 2024-06-30 | (m) | $314.57M | (m) | $90.30M | $335.94M | $40.98M | (m) |
| 2024-03-31 | (m) | $305.95M | (m) | $69.12M | $288.75M | $43.02M | (m) |
| 2023-12-31 | (m) | $307.27M | (m) | $236.88M | $278.29M | $40.76M | (m) |
| 2023-09-30 | (m) | $289.92M | (m) | $267.85M | $255.15M | $42.08M | (m) |
| 2023-06-30 | (m) | $276.86M | (m) | $354.83M | $260.06M | $42.69M | (m) |
| 2023-03-31 | (m) | $290.97M | (m) | $408.86M | $246.78M | $40.68M | (m) |
| 2022-12-31 | $1.14B | $310.50M | $466.00M | $432.30M | $244.38M | $35.41M | 3.68× |
| 2022-09-30 | $757.52M | $267.28M | $57.04M | $464.11M | $236.36M | $40.43M | 2.83× |
| 2022-06-30 | $846.96M | $251.62M | $91.30M | $547.35M | $208.31M | $30.46M | 3.37× |
| 2022-03-31 | $919.82M | $231.07M | $158.30M | $593.66M | $167.86M | $25.05M | 3.98× |
| 2021-12-31 | $1.04B | $218.96M | $84.39M | $829.90M | $122.07M | $26.91M | 4.73× |
| 2021-09-30 | $1.13B | $199.71M | $95.10M | $928.60M | $110.42M | $28.02M | 5.68× |
| 2021-06-30 | $680.37M | $197.99M | $62.81M | $517.43M | $100.13M | $28.41M | 3.44× |
| 2021-03-31 | $741.13M | $166.97M | $65.13M | $588.45M | $87.56M | $23.68M | 4.44× |
| 2020-12-31 | $815.84M | $199.05M | $48.67M | $688.61M | $78.56M | $20.03M | 4.10× |
| 2020-09-30 | $880.23M | $195.87M | $209.35M | $600.21M | $70.67M | $20.38M | 4.49× |
| 2020-06-30 | $629.88M | $175.56M | $77.32M | $493.85M | $58.71M | $18.03M | 3.59× |
| 2020-03-31 | $467.40M | $176.64M | $74.14M | $331.68M | $61.58M | $14.16M | 2.65× |
| 2019-12-31 | $494.34M | $179.87M | $61.93M | $379.06M | $53.35M | $12.39M | 2.75× |
| 2019-09-30 | $297.21M | $137.97M | $51.61M | $186.70M | $58.91M | $12.51M | 2.15× |
| 2019-06-30 | $300.95M | $126.92M | $29.93M | $208.05M | $62.97M | $15.24M | 2.37× |
| 2019-03-31 | $188.38M | $112.66M | $34.28M | $93.81M | $60.29M | $13.75M | 1.67× |
| 2018-12-31 | $216.09M | $113.98M | $46.41M | $107.46M | $62.22M | $13.63M | 1.90× |
| 2018-09-30 | $225.82M | $101.83M | $34.53M | $130.89M | $60.40M | $12.24M | 2.22× |
| 2018-06-30 | $140.21M | $98.13M | $12.31M | $70.90M | $57.00M | $12.32M | 1.43× |
| 2018-03-31 | $164.02M | $104.38M | $33.67M | $80.02M | $50.33M | $11.91M | 1.57× |
| 2017-12-31 | $127.12M | $105.51M | $12.62M | $106.25M | $8.25M | $9.00M | 1.20× |
| 2017-09-30 | $153.57M | $91.53M | $11.21M | $135.02M | $7.34M | $9.19M | 1.68× |
| 2017-06-30 | $109.23M | $98.27M | $7.14M | $94.99M | $7.11M | $7.36M | 1.11× |
| 2017-03-31 | $123.26M | $93.02M | $9.09M | $106.69M | $7.48M | $8.22M | 1.33× |
| 2016-12-31 | $159.51M | $96.42M | $15.26M | $130.86M | $13.40M | $6.41M | 1.65× |
| 2016-09-30 | $192.45M | $95.98M | $25.32M | $157.72M | $9.41M | $9.25M | 2.01× |
| 2016-06-30 | $221.38M | $95.49M | $16.56M | $198.65M | $6.17M | $8.89M | 2.32× |
| 2016-03-31 | $236.69M | $84.15M | $33.98M | $196.60M | $6.11M | $6.69M | 2.81× |
| 2015-12-31 | $236.40M | $80.47M | $28.95M | $201.59M | $5.86M | $8.09M | 2.94× |
| 2015-09-30 | $228.40M | $35.03M | $196.19M | $26.39M | $5.82M | $12.72M | 6.52× |
| 2015-06-30 | (m) | $38.52M | $62.24M | (m) | (m) | $14.63M | (m) |
| 2015-03-31 | (m) | (m) | $80.35M | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | $29.87M | $87.18M | (m) | (m) | $11.54M | (m) |
| 2014-09-30 | (m) | (m) | $22.32M | (m) | (m) | (m) | (m) |
| 2014-06-30 | (m) | (m) | $17.67M | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | $30.50M | (m) | (m) | (m) | (m) |
| 2012-12-31 | (m) | (m) | $5.75M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |